Lv3
390 积分 2020-10-12 加入
Long-term follow-up of VIALE-A: Venetoclax and azacitidine in chemotherapy-ineligible untreated acute myeloid leukemia
1个月前
已完结
Venetoclax and decitabine vs intensive chemotherapy as induction for young patients with newly diagnosed AML
1个月前
已完结
Lisaftoclax in Combination with Alrizomadlin Overcomes Venetoclax Resistance in Acute Myeloid Leukemia and Acute Lymphoblastic Leukemia: Preclinical Studies
1个月前
已完结
Targeting BCL-2 in Hematologic Malignancies
2个月前
已关闭
Fixed-Duration Acalabrutinib Combinations in Untreated Chronic Lymphocytic Leukemia
5个月前
已完结
Chronic lymphocytic leukaemia
5个月前
已完结
Cancer and myositis: Who, when, and how to screen
7个月前
已完结
Cancer risk in dermatomyositis: a systematic review of the literature
7个月前
已完结
Application of Risk-Based Cancer Screening in Patients With Dermatomyositis
7个月前
已完结
Thrombopoietin receptor agonists and risk of portal vein thrombosis in patients with liver disease and thrombocytopenia: A meta-analysis
7个月前
已完结
皖公网安备34019202002308
